Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1972 May;25(5):410–414. doi: 10.1136/jcp.25.5.410

Studies on the prekallikrein-bradykininogen system in liver disease

David Stewart 1, Laurence M Blendis 1, Roger Williams 1,1
PMCID: PMC477336  PMID: 5046072

Abstract

The plasma prekallikrein-bradykininogen system was studied in 45 patients with chronic liver disease since its activation with increased liberation of kinin into the plasma could account for some of the clinical manifestations of cirrhosis, namely, vasodilatation, hypotension, and increased capillary permeability.

A significant reduction in plasma bradykininogen was found in the cirrhotic patients as compared with control groups of normal subjects and hospital inpatients. The mean plasma prekallikrein was not significantly different and only five patients with liver disease had reduced levels. The most likely explanation for the low plasma bradykininogen was impairment of synthesis by the cirrhotic liver, the usually normal prekallikrein levels making the other possibility of increased activation of bradykininogen to bradykinin in the plasma less likely.

Full text

PDF
411

Images in this article

411Image
on p.411

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Back N., Steger R. Effect of heparin on the kinin-forming activity of trypsin, plasmin, and various kallikreins. Proc Soc Exp Biol Med. 1970 Mar;133(3):740–743. doi: 10.3181/00379727-133-34555. [DOI] [PubMed] [Google Scholar]
  2. Blendis L. M., Ramboer C., Williams R. Studies on the haemodilution anaemia of splenomegaly. Eur J Clin Invest. 1970 Mar;1(1):54–64. doi: 10.1111/j.1365-2362.1970.tb00597.x. [DOI] [PubMed] [Google Scholar]
  3. Brocklehurst W. E., Mawer G. E. The purification of a kininogen from human plasma. Br J Pharmacol Chemother. 1966 Aug;27(2):256–276. doi: 10.1111/j.1476-5381.1966.tb01661.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carretero O. A., Nasjletti A., Inon A., Dohmen R. S. Kinins, kininogen and kininogenase activity in pregnancy and hepatic failure. Am J Med Sci. 1970 Mar;259(3):182–186. doi: 10.1097/00000441-197003000-00005. [DOI] [PubMed] [Google Scholar]
  5. Colman R. W., Mason J. W., Sherry S. The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states. Ann Intern Med. 1969 Oct;71(4):763–773. doi: 10.7326/0003-4819-71-4-763. [DOI] [PubMed] [Google Scholar]
  6. Colman R. W., Mattler L., Sherry S. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins. J Clin Invest. 1969 Jan;48(1):11–22. doi: 10.1172/JCI105959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Colman R. W., Mattler L., Sherry S. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein. J Clin Invest. 1969 Jan;48(1):23–32. doi: 10.1172/JCI105971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DINIZ C. R., CARVALHO I. F. A micromethod for determination of bradykininogen under several conditions. Ann N Y Acad Sci. 1963 Feb 4;104:77–89. doi: 10.1111/j.1749-6632.1963.tb17654.x. [DOI] [PubMed] [Google Scholar]
  9. Dedichen J., Vystyd J. Kininase activity of plasma from patients with arteriosclerosis, diabetes and hepatitis. Scand J Clin Lab Invest Suppl. 1969;107:125–127. [PubMed] [Google Scholar]
  10. ERDOES E. G., SLOANE E. M., WOHLER I. M. CARBOXYPEPTIDASE IN BLOOD AND OTHER FLUIDS. I. PROPERTIES, DISTRIBUTION, AND PARTIAL PURIFICATION OF THE ENZYME. Biochem Pharmacol. 1964 Jun;13:893–905. doi: 10.1016/0006-2952(64)90033-4. [DOI] [PubMed] [Google Scholar]
  11. Greenbaum L. M., Yamafuji K. The in vitro inactivation and formation of plasma kinins by spleen cathepsins. Br J Pharmacol Chemother. 1966 May;27(1):230–238. doi: 10.1111/j.1476-5381.1966.tb01658.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LEWIS G. P. Active polypeptides derived from plasma proteins. Physiol Rev. 1960 Oct;40:647–676. doi: 10.1152/physrev.1960.40.4.647. [DOI] [PubMed] [Google Scholar]
  13. OATES J. A., MELMON K., SJOERDSMA A., GILLESPIE L., MASON D. T. RELEASE OF A KININ PEPTIDE IN THE CARCINOID SYNDROME. Lancet. 1964 Mar 7;1(7332):514–517. doi: 10.1016/s0140-6736(64)92907-1. [DOI] [PubMed] [Google Scholar]
  14. Rocha e Silva M., Reis M. L., Ferreira S. H. Release of kinins from fresh plasma under varying experimental conditions. Biochem Pharmacol. 1967 Sep 9;16(9):1665–1676. doi: 10.1016/0006-2952(67)90241-9. [DOI] [PubMed] [Google Scholar]
  15. Talamo R. C., Haber E., Austen K. F. A radioimmunoassay for bradykinin in plasma and synovial fluid. J Lab Clin Med. 1969 Nov;74(5):816–827. [PubMed] [Google Scholar]
  16. Webster M. E. Human plasma kallikrein, its activation and pathological role. Fed Proc. 1968 Jan-Feb;27(1):84–89. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES